Central nervous system stimulants: neuropharmacological mechanisms
- PMID: 2899318
- DOI: 10.1007/978-3-642-73223-2_5
Central nervous system stimulants: neuropharmacological mechanisms
Abstract
The mechanisms underlying CNS-stimulant drug discrimination are discussed. Although different doses of CNS stimulants may produce qualitatively different cues, it appears that a relatively low dose of d-amphetamine (e.g., 1 mg/kg) elicits a "general" CNS-stimulant cue. Presynaptically, this cue may primarily depend on release of endogenous dopamine whereas inhibition of dopamine reuptake, per se, is insufficient to elicit the cue. Postsynaptically, the involvement of both dopamine D-1 and D-2 receptors is implicated. Furthermore, in the drug discrimination situation, D-1/D-2 receptors may be coupled differently than in dopamine-dependent locomotor activation. Anatomically, CNS-stimulant drug discrimination may depend primarily on mesolimbic dopamine systems.
Similar articles
-
d-amphetamine "cue" generalizes to social defeat stress: behavioral sensitization and attenuated accumbens dopamine.Psychopharmacology (Berl). 1999 Nov;147(2):190-9. doi: 10.1007/s002130051160. Psychopharmacology (Berl). 1999. PMID: 10591887
-
Discriminative properties of the psychostimulant dl-cathinone in a two lever operant task. Lack of evidence for dopaminergic mediation.Neuropharmacology. 1986 Jan;25(1):85-94. doi: 10.1016/0028-3908(86)90063-8. Neuropharmacology. 1986. PMID: 2869439
-
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.Synapse. 2001 Jan;39(1):32-41. doi: 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3. Synapse. 2001. PMID: 11071707
-
Brain mechanisms of drug reward and euphoria.Psychiatr Med. 1985;3(4):445-60. Psychiatr Med. 1985. PMID: 2893431 Review.
-
Dopamine reuptake transporter (DAT) "inverse agonism"--a novel hypothesis to explain the enigmatic pharmacology of cocaine.Neuropharmacology. 2014 Dec;87:19-40. doi: 10.1016/j.neuropharm.2014.06.012. Epub 2014 Jun 19. Neuropharmacology. 2014. PMID: 24953830 Review.
Cited by
-
Human drug discrimination: A primer and methodological review.Exp Clin Psychopharmacol. 2016 Aug;24(4):214-28. doi: 10.1037/pha0000077. Exp Clin Psychopharmacol. 2016. PMID: 27454673 Free PMC article. Review.
-
Pharmacogenetic tools for the development of target-oriented cognitive-enhancing drugs.NeuroRx. 2006 Jan;3(1):106-16. doi: 10.1016/j.nurx.2005.12.004. NeuroRx. 2006. PMID: 16490417 Free PMC article. Review.
-
Selective genetic disruption of dopaminergic, serotonergic and noradrenergic neurotransmission: insights into motor, emotional and addictive behaviour.J Psychiatry Neurosci. 2016 Apr;41(3):169-81. doi: 10.1503/jpn.150028. J Psychiatry Neurosci. 2016. PMID: 26505143 Free PMC article.